| Study to Evaluate the Efficacy and Safety of CKD-352 (NCT04548427) | Chong Kun Dang Pharmaceutical | 2020-09-22 |
| Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects (NCT04488900) | Chong Kun Dang Pharmaceutical | 2020-07-06 |
| Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. (NCT04471441) | Chong Kun Dang Pharmaceutical | 2020-06-30 |
| A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393) (NCT04431687) | Chong Kun Dang Pharmaceutical | 2020-06-15 |
| A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 (NCT04448223) | Chong Kun Dang Pharmaceutical | 2020-06-11 |
| The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy (NCT04667975) | Chong Kun Dang Pharmaceutical | 2020-05-21 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects (NCT04260438) | Chong Kun Dang Pharmaceutical | 2020-04-08 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389 (NCT04322032) | Chong Kun Dang Pharmaceutical | 2020-04-06 |
| A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 (NCT04258865) | Chong Kun Dang Pharmaceutical | 2020-03-25 |
| A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396 (NCT04246190) | Chong Kun Dang Pharmaceutical | 2020-02-24 |
| A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers (NCT04223895) | Chong Kun Dang Pharmaceutical | 2020-02-01 |
| A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375 (NCT04221360) | Chong Kun Dang Pharmaceutical | 2020-01-29 |
| Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects (NCT04746287) | Chong Kun Dang Pharmaceutical | 2020-01-14 |
| A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 (NCT04255589) | Chong Kun Dang Pharmaceutical | 2020-01-06 |
| Compare the Pharmacokinetics and Safety of CKD-391 (NCT04354987) | Chong Kun Dang Pharmaceutical | 2019-10-30 |
| Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet (NCT04388215) | Chong Kun Dang Pharmaceutical | 2019-10-23 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers (NCT04075643) | Chong Kun Dang Pharmaceutical | 2019-09-19 |
| Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) (NCT04083872) | Chong Kun Dang Pharmaceutical | 2019-09-06 |
| Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) (NCT04083846) | Chong Kun Dang Pharmaceutical | 2019-09-06 |
| Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 (NCT04312698) | Chong Kun Dang Pharmaceutical | 2019-08-29 |
| Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1 (NCT04156685) | Chong Kun Dang Pharmaceutical | 2019-08-06 |
| A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012 (NCT04035538) | Chong Kun Dang Pharmaceutical | 2019-08-01 |
| Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) (NCT04069065) | Chong Kun Dang Pharmaceutical | 2019-07-31 |
| Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers (NCT04019743) | Chong Kun Dang Pharmaceutical | 2019-07-28 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers (NCT04272502) | Chong Kun Dang Pharmaceutical | 2019-06-04 |
| A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation (NCT03950843) | Chong Kun Dang Pharmaceutical | 2019-04-23 |
| The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375 (NCT03848637) | Chong Kun Dang Pharmaceutical | 2019-04-14 |
| A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers (NCT03920579) | Chong Kun Dang Pharmaceutical | 2019-04-01 |
| Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers (NCT03887858) | Chong Kun Dang Pharmaceutical | 2019-03-11 |
| Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal (NCT03887871) | Chong Kun Dang Pharmaceutical | 2019-03-11 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers (NCT03858725) | Chong Kun Dang Pharmaceutical | 2019-02-26 |
| Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults (NCT03849287) | Chong Kun Dang Pharmaceutical | 2019-02-25 |
| Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers (NCT03868072) | Chong Kun Dang Pharmaceutical | 2019-02-22 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults (NCT03849495) | Chong Kun Dang Pharmaceutical | 2019-02-19 |
| A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 (NCT03802162) | Chong Kun Dang Pharmaceutical | 2019-02-15 |
| Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg (NCT03928470) | Chong Kun Dang Pharmaceutical | 2019-01-29 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition (NCT03849339) | Chong Kun Dang Pharmaceutical | 2019-01-28 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults (NCT03849261) | Chong Kun Dang Pharmaceutical | 2019-01-14 |
| The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition (NCT03738449) | Chong Kun Dang Pharmaceutical | 2019-01-08 |
| Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus (NCT05043467) | Chong Kun Dang Pharmaceutical | 2019-01-02 |
| Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM) (NCT04224350) | Chong Kun Dang Pharmaceutical | 2018-12-17 |
| A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 (NCT03762369) | Chong Kun Dang Pharmaceutical | 2018-12-07 |
| A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate (NCT04204603) | Chong Kun Dang Pharmaceutical | 2018-11-30 |
| Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers (NCT03748212) | Chong Kun Dang Pharmaceutical | 2018-10-24 |
| A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration (NCT04857177) | Chong Kun Dang Pharmaceutical | 2018-10-19 |
| Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients (NCT04539652) | Chong Kun Dang Pharmaceutical | 2018-09-20 |
| Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337 (NCT03793985) | Chong Kun Dang Pharmaceutical | 2018-09-05 |
| Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients (NCT03749356) | Chong Kun Dang Pharmaceutical | 2018-09-05 |
| A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects (NCT03726866) | Chong Kun Dang Pharmaceutical | 2018-08-31 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults (NCT03646799) | Chong Kun Dang Pharmaceutical | 2018-08-30 |
| A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects (NCT03609606) | Chong Kun Dang Pharmaceutical | 2018-08-09 |
| Pharmacokinetics and Safety Profile of CKD-333 (NCT03659149) | Chong Kun Dang Pharmaceutical | 2018-08-08 |
| Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308 (NCT03616392) | Chong Kun Dang Pharmaceutical | 2018-07-25 |
| Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg (NCT03601910) | Chong Kun Dang Pharmaceutical | 2018-07-16 |
| The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 (NCT03726853) | Chong Kun Dang Pharmaceutical | 2018-05-29 |
| Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers (NCT03671941) | Chong Kun Dang Pharmaceutical | 2018-05-25 |
| CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects (NCT03713892) | Chong Kun Dang Pharmaceutical | 2018-05-23 |
| The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes (NCT03641352) | Chong Kun Dang Pharmaceutical | 2018-05-02 |
| CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1) (NCT03569579) | Chong Kun Dang Pharmaceutical | 2018-04-16 |
| Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet (NCT03583905) | Chong Kun Dang Pharmaceutical | 2018-04-04 |
| Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome (NCT03794492) | Chong Kun Dang Pharmaceutical | 2018-03-31 |
| A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects (NCT03444402) | Chong Kun Dang Pharmaceutical | 2018-03-02 |
| Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet (NCT03437785) | Chong Kun Dang Pharmaceutical | 2018-01-16 |
| Retrospective Observational Study on GERD Management in General Hospitals in Korea (NCT06974903) | Chong Kun Dang Pharmaceutical | 2018-01-03 |
| Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. (NCT04102943) | Chong Kun Dang Pharmaceutical | 2017-11-30 |
| Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes (NCT03739125) | Chong Kun Dang Pharmaceutical | 2017-11-07 |
| A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337 (NCT03382756) | Chong Kun Dang Pharmaceutical | 2017-10-12 |
| Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg (NCT04511000) | Chong Kun Dang Pharmaceutical | 2017-10-11 |
| A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy (NCT04521023) | Chong Kun Dang Pharmaceutical | 2017-09-20 |